Glyphosate, the active ingredient in the widely used weed and grass-killer Roundup, has been linked to an increased risk of non-Hodgkin’s Lymphoma as well as other cancers.
The International Agency for Research on Cancer (IARC), a division of the World Health Organization, declared the herbicide Roundup (glyphosate) as a “probable human carcinogen” in March 2015. The warning was based on “convincing evidence” that glyphosate causes cancer in laboratory rats and mice. In humans, there is “limited evidence” linking Roundup and cancer, including non-Hodgkin’s lymphoma and DNA/chromosomal damage.
California will become the 1st state to require cancer warning labels on Roundup and other glyphosate-based herbicides. Monsanto will have roughly 1 year to add “Proposition 65” warning labels to Roundup after glyphosate is listed as a carcinogenic chemical on July 7.
Roundup is primarily associated with Non-Hodgkin Lymphoma, a cancer that starts in the immune system nearly anywhere in the body. It is a blood cancer that grows in lymphocytes, which are white blood cells in the immune system that help the body fight diseases.
If you or a loved one were exposed to Roundup and were then diagnosed with:
- non-Hodgkin’s Lymphoma
You may be entitled to significant compensation from the manufacturer.
There are time deadlines to file a claim so don’t wait — act now.